Оценка эффективности метода усиленной наружной контрпульсации в комплексном лечении больных сердечной недостаточностью
Диссертация
ХСН является системной патологией. Одним из основных органов мишеней являются почки. Нарушение функции почек выявлено более чем у половины пациентов с недостаточностью кровообращения II-III ФК по NYHA. К сожалению, прогноз больных ХСН ухудшается параллельно с развитием дисфункции почек. Снижение скорости клубочковой фильтрации (СКФ) и повышение креатинина ассоциируются с высокой смертностью… Читать ещё >
Список литературы
- Абрашкина НН, Игонина НА, Леонова АР и соавт. ИНВИТРО диагностика. М.2005: 173−175
- Арутюнов ГП. Патофизиологические процессы в почках у больных ХСН. Журнал сердечная недостаточность 2008−5(49) 234−249
- Арутюнов ГП, Кафарская ЛИ, Власенко ВК. Микрофлора кишечника у больных хронической сердечной недостаточностью как возможный фактор возникновения и генерализации системного воспаления. Журнал сердечная недостаточность 2003−4(5):256−260
- Байрамукова MX. Метод наружной контрпульсации в лечении больных ишемической болезнью сердца. Дис.кан.мед.наук.М 2006
- Бокерия ЛА, Ермоленко МЛ, Байрамукова MX. Наружная контрпульсация эффективный метод лечения рефрактерной стенокардии. Бюллетень НЦССХ им А. Н. Бакулева РАМН 2005−6:6−9
- Беленков Ю.Н.Б Мареев В. Ю. Принципы рационального лечения сердечной недостаточности. «Медиа Медика», Москва, 2000, с.266
- Васюк Ю.А., Хадзегова А. Б., Ющук Е.Н и соавт. Гибернирующий миокард и процессы постинфарктного ремоделирования левого желудочка. Журнал сердечная недостаточность 2001 -2(4)
- Воробьев П. А., Клинико-экономический анализ, Москва, Ньюдиамед, 2004
- Габрусенко СА, Сергиенко ИВ. Метод наружной контрпульсации в лечении больных ишемической болезнью сердца
- Гендлин ГЕ, Самсонова ЕВ, Бухало ОВ, Сторожаков ГИ. Методики исследования качества жизни у больных хронической недостаточностью кровообращения. Журнал Consilium MedicumToM l. N 2.2000
- Даниелян МО. Прогноз и лечение хронической сердечной недостаточности (данные 20-и летнего наблюдения). Автореф.дис.канд.мед.наук. Москва. 2001.
- Ермоленко MJI, Байрамукова MX, Никонов СФ и соавт. Метод наружной контрпульсации в лечении больных ИБС. Методические рекомендации. М., НЦССХ им. А. Н. Бакулева РАМН, 2005:22
- Земченков AIO, Томилина НА. «К/ДОКИ» обращается к истокам хронической почечной недостаточности (О новом разделе Рекомендаций K/DOQI по диагностике, классификации и оценке тяжести хронических заболеваний почек) Нефрология и диализ. 2004−6(3):204−221
- Кобалава ЖД, Дмитрова ТБ. Кардиоренальный синдром. Русский медицинский журнал.2003,11(12)
- Либис РА, Коц ЯИ, Агеев ФТ, Мареев ВЮ. Качество жизни как критерий успешной терапии больных хронической сердечной недостаточностью. Русс. мед. журн. 1999
- Люсов В, Толпекин В, Дюков И. Ритмическая пневмокомпрессия нижних конечностей у больных острым инфарктом миокарда и ее влияние на центральную гемодинамику и реологические свойства крови. Кардиология 1996−36−9-24
- Малахов ВВ, Габрусенко СА, Сергиенко ИВ и соавт. Метод наружной контрпульсации в лечении больных сердечной недостаточностью. Кардиологический вестник 2008−3(15):22−27
- Мареев В.Ю. Фармако-экономическая оценка использования ИАПФ в амбулаторном лечении больных с сердечной недостаточностью (ФАСОН). Журнал Сердечная недостаточность 2002−3(1):38−39
- Мареев ВЮ, Агеев ФТ, Арутюнов ГП и соавт. Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (третий пересмотр). Журнал Сердечная недостаточность 2009−2(52):64−106
- Мареев ВЮ, Беленков ЮН. Журнал сердечная недостаточность 8, 39, 2007 стрЮ
- Новик А.А., Ионова Т. И., Кайнд П. Концепция исследования качества жизни в медицине. Санкт-Петербург-ЭЛБИ-1999,стр139
- Ольбинская ЛИ, Игнатенко СБ. Роль системы цитокинов в патогенезе хронической сердечной недостаточности. Тер. архив 2001−12−82−84
- Ольхова ЕБ, Зарубина СА, Быковский В А. Эхографическая оценка ренальной гемодинамики у детей разного возраста. Ультразвуковая диагностика в акушерстве, гинекологии, педиатрии, 1999−3:212−218
- Преображенский Д.В., Сидоренко Б. А., Сопалева Ю. В., Иосава И. К. Физиология и фармакология ренин-ангиотензиновой системы, Кардиология, 1997, 11,91−95.
- Резник ЕВ, Гендлин ГЕ, Сторожаков ГИ и еоавт. Почечная гемодинамика у больных хронической сердечной недостаточностью. Журнал Сердечная недостаточность 2007−3(41):118−123
- Резник ЕВ, Гендлин ГЕ, Сторожаков ГИ. Дисфункция почек у больных хронической сердечной недостаточностью: патогенез, диагностика, лечение. Журнал Сердечная недостаточность 2005,6(34):245−250
- Секция артериальной гипертонии ВНОК. Профилактика. Диагностика и лечение артериальной гипертензии. Российские рекомендации (второй пересмотр) М., 2005
- Сергиенко ИВ, Ежов MB, Малахов ВВ и соавт. Метод наружной контрпульсации в лечении больных ишемической болезнью сердца. Кардиология 2004- 11:92−96
- Струтынский АВ. Эхокардиограмма: анализ и интерпретация, М.2003:104−108
- Терещенко СН, Демидова ИВ. Почечная функция при хронической сердечной недостаточности у больных пожилого и старческого возраста. Сердце. 2002- 1(5): 251−256
- Томилина НА, Волгина ГВ, Бикбов БТ, Ким ИГ. Проблема сердечнососудистых заболеваний при хронической почечной недостаточности. Нефрология и диализ, 2003−5(1): 15−24
- Фомин ИВ, Беленков ЮН, Мареев ВЮ и др. Распространенность ХСН в Европейской части Российской Федерации данные ЭПОХА-ХСН, Журнал сердечная недостаточность 2006- 7(1) 4−7
- Хубутия МШ, Шумаков ДВ, Гасанов ЭК. Наружная контрпульсация метод неинвазивного вспомогательного кровообращения. Вестник трансплантологии и искусственных органов 2004- 2:17−19
- Шумаков ВИ, Толпекин BE. Вспомогательное кровообращение: достижения и проблемы. Кардиология, 1976−1:10−16
- Шумаков ВИ, Толпекин BE. Наружная контрпульсация: опыт НИИ транслантологии и искусственных органов. Кардиология 2005−2:4−6
- Юревичуте Г. И. Применение мышечной контрпульсации в комплексном лечении больных хронической сердечной недостаточностью со сниженной фракцией выброса левого желудочка, дисс, Москва 2008
- Abbottsmith CW, Chung ES, Varricchione T et al. Enhanced external counterpulsation improves exercise duration and peak oxygen consumption in older patients with heart failure: a subgroup analysis of the PEECH trial. Congest Heart Fail 2006−12(6):307−11
- Agabiti-Rosei E, Muiesan ML. Hypertensive left ventricular hypertrophy: pathophysiological and clinical issues. Blood Press 2001- 10: 288−298.
- Amsterdam EA, Banas J, Criley JM et al. Clinical assessment о f exrternal pressure circulatory assistance in acute myocardial infarction. Report of a cooperative clinical trial. Am J Cardiol. 1980−45:349−356
- Anand I., Fisher L., Chiang Y.-T. et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the valsartan heart failure trial (Val-HeFT). Circulation 2003−107:1276−1281.
- Applebaum RM, Kasliwal R, Tunick PA et al. Sequential external counterpulsation increases cerebral and renal blood flow. Am Heart J 1997−133(6):611−5
- Appleton Ch.P., Hatle L.K., Popp R.L. Relation of transmittal flow velocity patterns to left ventricular diastolic function: new insights from acombined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 1988−12:426−40.
- Arora R, Chen HJ, Rabbani L. Effects of enhanced counterpulsation on vascular cell release of coagulation factors. Heart Lung. 2005−34(4):252−6
- Arora RR, Chou TM, Jain D et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on cxercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol 1999 Jun-33(7):1833−40
- Aspromonte N., Feola M., Scardovi A., Coletta C. et al. Early diagnosis of congestive heart failure: clinical utility of B-type natriuretic peptide testing associated with Doppler echocardiography. J Cardiovasc Med 2006- 7: 406−411
- Banas JS, Brilla A, Soroff HS. Evaluation of external counterpulsation for treatment severe angina pectoris. Circulation Suppl. II, 1972, 46, 74
- Barness G. Enhanced external counterpulsation in unrevascularizable patients. Curr Interv Cardiol Rep, 2001 -3(l):37−43
- Barness G, Feldman AM, Holmes DR et al. The International EECP Patient Registry (IEPR): design, methods, baseline characteristics and acute results. Clin Cardiol 2001−24(6):435−42
- Bettencourt P, Ferreira A, Dias P et al. Evaluation of brain natriuretic peptide in diagnosis of heart failure. Cardiology 2000−93(l-2)-19−25
- Birtwell WC, Giron F, Soroff HS. Support of systemic circulation and left ventricular assist by synchronous pulsation of extramural pressure. Trans Am Soc Artif Intern Organs. 1965- 11:43−52.
- Birtwell WC, Homma J, Hui JS et al. The Present Status of External Counterpulsation. In book «Assisted • Circulation», Springer-Verlag Berlin Heidelberg New York, 1979:71−78
- Bolli R. Circulation 1990- 82 (3): 723−38
- Boneti PO MD, David R, Holmes, Jr, MD, FACC, Annual of the American College of cardiology, Vol. 41 № 11, 2003
- Bonetti PO, Barness GW, Keelan PC et al. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol 2003−41:1761−1768
- Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk- Arterioscler Thromb Vase Biol 2003- 23:168−75.
- Brutsaert D.L., Sys S.U., Gillebert T.C. Diastolic failure: pathophysiology and therapeutic implications, heart function. J Am Coll Cardiol 1993−22:318−25.
- Cai D, Wu R, Gu P et al. The effects of enhanced external counterpulsation in treating lower extremity arterial occlusive disease. Shanghai Medicine 1985−8(12):699−701
- Cai D, Wu R, Shao Y. Experimental study of the effect of external counterpulsation on blood circulation in the lower extremities. Clin Invest Med. 2000−23:239−247
- Casey DP, Conti CR, Nichols WW. Effect of enhanced external counterpulsation on inflammatory cytokines and adhesion molecules in patients with angina pectoris and angiographic coronary artery disease. Am J Cardiol. 2008−101(3):300−2
- Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol. 1997−30:325−333
- Chen J. Optic atrophy treated with enhanced external counterpulsation. Zhejiang Medical Information. 1995- 1:53
- Chen W., Gibson D. Relation of isovolumic relaxation to left ventricular wall movement in man. Br. Heart J. l979.42.51−56.
- Cheng V., Kazanegra R., Garcia A. et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001−37:386−391
- Cohen LS, Mullins CB, Mitchel JH Sequenced external counterpulsation and inraaortic balloon pumping in cardiogenic schock. Am J Cardiol. 1973- 32(5):656−661)
- Conrad KP, Dunn MJ. Renal prostaglandins and other eicosanoids. In Windhager E.E. «Renal physiology» N. Y, Oxford University Press (1992), chapter 35
- Comerota AJ, Chouhan V, Harada RN et al. The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Ann Surg 1997−226(3):306−13
- Coresh J, Astor B, Sarnak MJ. Evidence for increased cardiovascular disease risk in patients with chronic kidney disease. Curr Opin Nephrol Hypertens.2004−13(l): 73−81
- Corson MA, James NL, Latta SE, Nerem RM, Berk ВС, Harrison DG. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ Res. 1996−79:984−991
- Cowie MR, Fox KF, Wood DA et al. Hospitalization of patients with heart failure: a population-based study. Eur Heart J.2002−23(ll):877−885
- Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev. 1995−75:519−560
- Dargie HJ, McMurray J 1997 Managing Heart Failure in Primary Care. Blackwell Healthcare Communication, London 23−34
- De Bold A J, Bruneau BG, De Bold K. Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc Res. 1996−31(1):7−18
- Dennis CE, Moreno JR, Half DF et al. Studies on external counterpulsation as a potential means for acute left heart failure. Trans Am Soc Artif Intern Organs. 1963- 9:186−191
- Dockery F, Rajkumar C, Bulpitt CJ et al. Enhanced external counterpulsation does not alter arterial stiffness in patients with angina. Clin Cardiol 2004−27(12):689−92
- Doughty RN, MacMahon S, Sharpe N. Beta-blockers in heart failure: Promising or proved? J Am Coll Cardiol. 1994- 23: 814−821
- Du G, Dong Y, Li J et al. Comparison of enhanced external counterpulsation and drug therapy in patients with ischemic cerebrovascular disease. Chinese Journal of Rehabilitation. 1996−11(3):112−113
- Dzau VJ. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch.Intern.Med 1993- 153: 937−942
- Eiskjaer H, Bagger JP, Mogensen CE et al. Enhanced urinary excretion ofalbumin in congestive heart failure: effect of ACE-inhibition. Scand Clin Labi1. vest 1992−52(3): 193−199
- Enright PL, Sherill DL Reference equations for the six minute walk in healthy adults/ Am.J.Respir.Crit.Care.Med 1998/158/1384−1387
- Esmaeilzadeh M, Khaledifar A, Maleki M et al. Evaluation of left ventricular systolic and diasrolic regional function after enhanced external counterpulsation therapy using strain rate imaging. Eur J of Echocardiography 2009, 10(1):120−126
- Estahbanaty G, Samiei N, Maleki M et al. Echocardiography characteristics including tissue Doppler imaging after enhanced external counterpulsation therapy. Am Heart Hosp J.2007,5(4), 241−6
- European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 1998- 19: 990−1003
- Feldman AM, Silver MA, Francis GS et al. Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 2006−48(6): 1189−1205
- Feldman AM, Silver MA, Francis GS et al. Treating heart failure with enhanced external counterpulsation: design of the Prospective Evaluation of EECP in Congestive Heart Failure (PEECH) trial. Jcard Fail 2005-ll (3):240−5
- Fricchione GL, Jaghab K, Lawson W et al. Psychosocial effects of enhanced external counterpulsation in the angina patient. Psychosomatics, 1995, Sep-Oct-36(5):494−7
- Fried LF, Shlipak MG, Crump G et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol. 2003−41 (8): 1364−1372
- Froschermaier SE, Werner D, Leike S et al. Enhanced external counterpulsation as new treatment modality for patients with erectile dysfunction. Urol Int 1998−61(3): 168−7
- Fung J, Yu C, Yip G et al. Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure. Am J Cardiol. 2003−92(4):406−410
- Gabbai FB. The glomerular capillary membrane a passive or active structure. J Lab Clin Med. 1995−125(4):419−420
- Gan L, Miocic M, Doroudi R, Selin-Sjogren L, Jern S. Distinct regulation of vascular endothelial growth factor in intact human conduit vessels exposed to laminar fluid shear stress and pressure. Biochem Biophys Res Commun. 2000−272:490−496
- Guidelines for the diagnosis and treatment of chronic heart failure. The Task Force of the Working Group on Heart Failure of the European Society of Cardiology. Eur Heart J 2001 Sep22(17) 1527−60
- Gurlek A, Kilikcap M, Dandachi R et al. Tumor necrosis factor-alpha in diastolic heart failure. Eur J Heart Failure 2000−2(Suppl.2): P28/10 381
- Haffner SM, Stem MP, Gruber KK et al. Microalbuminuria. Potential marker for increased cardiovascular risk factor on nondiabetic subjects? Arteriosclerosis 1990- 10(5):727−731
- Hillege HL, Girbes AR, de Kam PJ et al. Renal function, neurohormonal activation and survival in patients with chronic heart failure. Circulation 2000- 102(2)-203−210
- Hillege H, van Gilst W, de Zeeuw D et al. Renal function as a predictor of prognosis in chronic heart failure. Heart Fail Monit. 2002−2(3):78−84
- Hillege HL, Nitsch D, Pfeffer MA et al. Renal function as a predictor of outcome in a broad of patients with heart failure. Circulation 2006- 113(5):671−678
- Ho KK, Pinsky JL et al. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol. 1993−22(4 Suppl A):6A-13A
- Hotzel J, Tauchert M. Haemodynamic Response to External Counterpulsation. In book «Assisted Circulation», Springer-Verlag Berlin Heidelberg New York, 1979:79−84
- I to S, Abe K. Tubuloglomerular feedback. Jpn Heart J. 1996−37(2):153 163
- Iwanaga Y, Nishi I, Furuiichi S et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol. 2006−47(4):742−748
- Jackson EK. Adenosine: a physiological brake on renin release. Annu Rev Pharmacol Toxicol. 1991−31:1−35
- Jacobey A, Taylor W.J., Smith G. T et al. A new therapeutic approach to acute coronary occlusion. Surd. Forum 12,1961,225
- Jaffe WM. Dewhurst ТА. Otto CW et al. Influense of Doppler sample volume location on ventricular filling velocities. Am.J.Cardiol/1991.68.550−552
- Jones CA, Francis ME, Eberhardt MS et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 2002−39(3):445−459
- Kantrowitz A., Kantrowitz A. Experimental augmentation of coronary flow by retardation of arterial pressure pulse. Surgery. 1953- 34(4):678−687.
- Kaptchuk TJ, Goldman P, Stone DA, Stason WB. Do medical devices have enhanced placebo effects? J Clin Epidemiol. 2000−53:786−792
- Keith M, Geranmayegan A, Sole M et al. Increased oxidative stress in patients with congestive heart failure. J Am.Coll.Cardiol 1998−31:1352−6
- Kern MJ, Aguirre FV, Tatineni S, et al. Enhanced coronary blood flow velocity during intraaortic balloon counterpulsation in critically ill patients. J Am Coil Cardiol 1993,21:359−68.
- Kern MJ, Aguirre F, Bach R, Donohue T, Siegel R, Segal J. Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation 1993−87:500−11.
- Khan A, Flett M, Yalamarthi S et al. The role of the intea-aortic ballon pump counterpulsation (IABP) in emergency surgery. Surgen. 2003−1:279−282
- Kind P. Quality of Life and Pharmaco-economics in Clinical Trials. 2th ed. / Ed. Spiker., Philadelphia: Lippincott, Raven Publishers, 1996−191−201
- Klahr S, Schreiner G, Ichikawa I. The progression of renal disease. N Engl J Med. 1988−318 (25): 1657−1666
- Konta T, Hao Z, Abiko H et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. Kidney Int 2006:70(4):751−756
- Kuang T. Pilot study of EECP on urinary system calculus. People Military Medicine 1999−42(1)-16−17
- Kuchan MJ, Frangos JA. Shear stress regulates endothelin-1 release via protein kinase С and cGMP in cultured endothelial cells. Am J Physiol. 1993−264:H150−156
- Labovitz A.J., Pearson A.C. Evaluation of left ventricular diastolic function: clinical relevance and recent Doppler echocardiographic insights. Am Heart J 1987−114:836−51.
- Lainchbury JG, Campbell E, Frampton CM et al. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol. 2003−42(4):728−735
- Latini R, Masson S, Anand I et al. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J.2004−25(4):292−299
- Lawson WE, Kennard ED, Holubkov R, et al. Benefit and safety of enhanced external counterpulsation in treating coronary artery disease patients with a history of congestive heart failure. Cardiology 2001−96:78−84
- Lawson WE, Hui JC, et al. Can angiographic findings predict which coronary patients will benefit from enhanced external counterpulsation? Am J Cardiol 1996- 77(12):1107−1109
- Lawson WE, Hui JC, Guo T et al. Prior revascularization increases the effectiveness of enhanced external counterpulsation. Cardiol 1998- 21(ll):841−844
- Lawson WE, Hui JC, Kennard ED et al. Effect of enhanced external counterpulsation on medically refractory angina patients with crectile dysfunction. Int J Clin Pract 2007- 61(5):757−62
- Lawson WE, Hui JC, Kennard ED. Two-year outcomes in patients with mild refractory angina treated with enhanced external counterpulsation (from IERP) Clin Cardiol 2006−29(2):69−73
- Lawson WE, Hui JC, Cohn PF. Long-term prognosis of patients with angina treated with enhanced external counterpulsation: five-year follow-up study. Clin Cardiol. 2000, 23(4):254−258
- Lawson WE, Hui JC, Oster ZH et al. Enhanced external counterpulsation as an adjunct to revascularization in unstable angina. Clin Cardiol 1997- 20(2): 178 180
- Lawson WE, Hui JCK, Zheng ZS, et al. Improved exercise tolerance following enhanced external counterpulsation: cardiac or peripheral effect? Cardiology. 1996−87:271−275
- Lawson WE, Hui JC, Zheng ZC et al. Tree-year sustained benefit from enhanced external counterpulsation in chronic angina pectoris. Am J Cardiol 1995, 75: 840−841
- Lawson WE, Silver MA, Hui JC et al. Angina patients with diastolic versus systolic heart failure demonstrate comparable immediate and one-year benefit from enhanced external counterpulsation. J Card Fail 2005−1 l (l):61−6
- Levenson J, Pernollet MG, Iliou MC et al. Cyclic GMP release by acute enhanced external counterpulsation. Am J Hypertens 2006- 19(8): 867−72
- Levey AS, Bosch JP, lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999−130(6):461−470
- Levey AS, Eckardt KU, Tsukamoto Y, et al.: Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67: 2089−2100, 2005
- Levine B, Kalman J, Mayer L et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990−323(4):236−241
- Levy D, Anderson K, Savage D, Echocardiographically detected left ventricular hypertrophy: prevalence and risk factor. The Framingham Heart Study. Ann Intern Med 1988:108−7-13
- Libman ES, Galperin MR, Grishina EE/ Methods for evaluation of the life quality in ophthalmologic patients
- Linnemeier G. Enhanced external counterpulsation a therapeutic option for patients with chronic cardiovascular problems. J Cardiovasc Manag 2002−13(6):20−25
- Linnemeier G, Michaels AD, Soran О et al. Enhanced external counterpulsation in the management of angina in the elderly. Am J Geriatr Cardiol 2003- 12(2) :90−4
- Linnemeier G, Rutter MK, Barness G et al. Enchanced external counterpulsation for the relief of angina in patients with diabetes: safety, efficacy and 1-year clinical outcomes. Am Heart J 2003−146(3):453−8
- Loh PH, Cleland JG, Louis A A et al. Enhanced external counterpulsation in the treatment of chronic refractory angina: a long-term follow-up outcome from the International EECP Patient Registry. Clin Cardiol 2008−31(4): 159−64
- Lubien E., DeMaria A., Krishnaswamy K. Utility of B-natriuretic peptide in diagnosing diastolic dysfunction. Circulation 2002- 105: 595−601
- Liu L, Zhou S, Wu G. Effects of external counterpulsation on the pulsatility of blood pressure in human subjects (Article in Chinese Sheng WU Yi Xuc Gong Cheng Xue Za Zhi 2002−19(3):467−70
- Liu Huizhao et al. Effects of external counterpulsation on fnterior ischemic optic neuropathy. Journal of Guiyang Medical Collegel994−19(4):346−347
- Lorenz JN, Weihprecht H, Schermann J et al. Characterization of the macula densa stimulus for renin secretion. Am J Physiol. 1990- 259 (lPt2):F186−193
- Lukowucz Т., Fisher M., Hense H. et al. BNP as a marker of diastolic dysfunction in the general population: Importance of left ventricular hypertrophy. Eur J Heart Failure 2005- 7: 525−531
- Maddox DA, Brenner BM. Glomerular ultrafiltration. In Brenner B.M. «The Kidney» W.B.Sauders CO 1991, chapter 6
- Maddox DA, Deen WM, Brenner BM. Glomerular filtration. In Windhager E.E. «Renal Physiology» N. Y, Oxford University Press, 1992, chapter 13
- Makino H, Hironaka K, Shikata К et al. Mesangial matrix act a mesangial channels to the juxtaglomerular zone. Nephron. 1994 -66(2): 181−188
- Manchanda A, Soran O. Enhanced external counterpulsation and future directions: step beyond medical management for patients with angina and heart failure. J Am Coll Cardiol. 2007 50(16): 1523−31
- Marenzi G, Lauri G, Guazzi M et al. Cardiac and renal dysfunction in chronic heart failure: relation to neurohumoral activation and prognosis. Am J Med Sci 2001- 321(6):359−366
- Margi P, Rao MA, Cangianiello S et al. Early impairment of renal hemodynamic reserve in patients with asymptomatic heart failure is restored by angiotensin II antagonism. Circulation. 1998−98(25):2849−2854
- Masuda D, Nohara R, Hirai T, et al. EECP improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina- evaluation by 13N-ammonia positron emission tomography. Eur Heart J 2001−22:16:1451−8
- Masuda D, Nohara K, Kataoka K, Hosokawa R, Kanbara N, Fujita M. Enhanced external counterpulsation promotes angiogenesis factors in patients with chronic stable angina. (abstr)Circulation. 2001- 104:445
- Maxwell AP, Ong HY, Nicholls DP Influence of progressive renal dysfunction in chronic heart failure. Eur J Heart Fail 2002- 4(2): 125−130
- Michaels AD, Accad M, Ports ТА. Left ventricular systolic unloading ang augmentation of intracoronary pressure and doppler flow during enhanced external counterpulsation. Circulation 2002- 106(10): 1237−1242
- Michaels AD, Barness GW, Soran О et al. Frequency and efficacy of repeat enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry) Am J Cardiol- 2005−95(3):394−7
- Michaels AD, Kennard ED, Kelsey SF, ct al. Does higher diastolic augmentation predict clinical benefit from enhanced external counterpulsation? Data from the International EECP Patient Registry (IEPR). Clin Cardiol 2001−24:453−8.
- Michaels AD, Linnemeier G, Soran О et al. Two-year outcomes after enchanced external counterpulsation for stable angina pectoris (from the International Patient Registry) Am J Cardiol 2004−93:461−464
- Michaels AD, Raisinghani A, Soran O. The effect of enhanced external counterpulsation on myocardial perfusion in patient with srable angina: a multicenter radionuclide study. Am Heart J 2005- 150(5): 1066−73
- Michowitz Y, Arbel Y, Wexler D et al. Predictive value of high sensitivity CRP in patients with diastolic heart failure. Int J Cardiol. 2008 Apr25 125(3):347−51
- Miyaguchi K, Yokota M, Hayashi H. Dependency of the pulsed Doppler derived transmitral filling profile on the sampling site. Am. Heart J. 1991.122.142 148
- McAlister FA, Ezekowitz J, Tonelli M et al. Renal insufficiency and Heart Failure. Circulation.2004- 109:1004−1009
- McAlister FA, Teo KK, Taher M et al. Insights into the contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J. 1999−138(lPt l):87−94
- McCullough PA, Due P, Omland T et al. B-type natriuretic peptide and renal function in diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis.2003−41(3):571−579
- McCullough PA, Henry TD, Kennard ED Residual high-grade angina after enhanced external counterpulsation therapy. Cardiovasc Revasc Med 2007−8(3):161−5
- McMurray J, McDonagh T et al. Trends in hospitalization for heart failure in Scotland 1980−1990, Eur. Heart J 1993−14(9)-1158−1162
- Moulopoulos S, Topaz S, Kolff W Diastolic ballon pumping (with carbon dioxide) in the aorta a mechanical assistance to the failing circulation. Am Heart J 1962,63: p669
- Nagueh S.F., Appleton C.P., Gillebert T.C., Marino P.N. et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography. European Journal of Echocardiography 2009, 10, 165−193.
- Nagueh S, Kopelen H, Quinones M. Assessment of left ventricular filling pressures by Doppler in the presence of atrial fibrillation. Circulation. 1996−94(9)-2138−2145.
- National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcomes Quality Initiative. Am J Kidney Dis 2: S1−266, 2002
- Nicholos WW, Estrada JC, Braith RW et al. Enhanced external counterpulsation treatment improves arterial wall properties and wave reflection characteristics in patients with refractory angina. J Am Coll Cardiol 2006−48(6): 1208−14
- Nishimura RA, Abel MD, Hatle LK et al. Assessment of diastolic function of the heart: Background and current application of Doppler echocardiography. Part II. Clinical studies. Mayo Clin.Proc. 1989.64.181−204
- Nishimura R.A., Tajik A.J. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician’s Rosetta Stone. J Am Coll Cardiol 1997−30:8−18.
- Novo G, Bagger JP, Carta R et al. Enhanced external counterpulsation fot treatment of refractory angina pectoris, J Cardiovasc Med (Hagerstown) 2006 May 7(5)-335−339
- Ohno M., Cheng C.P., Little W.C. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation 1994−89:2241−50.
- OMeara E, Chong KS, Gardner RS et al. The Modification of Diet in Renal Desease (MDRD) equations provide valid estimations of glomerular filtration rates in patients with advanced heart failure. Eur J Heart Fail.2006−8(l):63−67
- Papapetropoulos A, Garscia-Cardena G, Mardi JA et al. Nitris oxide production contrib utes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest. 1997−100:3131−9
- Paul M, Ganten D. The molecular basis of cardiovascular hypertrophy: the role of the renin-angiotensin system. J Cardiovasc Pharmacol 1992- 19 Suppl 5: S51−58.
- Piere O. Boneti, MD, David R, Holmes, Jr, MD, FACC, Annual of the American College of cardiology, Vol. 41 № 11, 2003
- Pinto-Sietsma SJ, Janssen WMT, Hillege HL et al. Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J AmSoc Nephrol 2000- 11(10): 1882−1888
- Qian X, Wu w, Zheng ZS et al. Effect of enhanced external counterpulsation on nitric oxide production in coronary disease (abstract) J Heart Dis 1999−1:193
- Qian Y, Zhou L. Chronic nephral dysfunction treated with enhanced external counterpulsation. Acta Universitatis Medicinalis Secondae Shanghai 1996−16(2):97
- Rahimtoola ShH. Circulation 1985- 72: V123-V135.
- Rajaram SS, Shanahan J, Ash С et al. Enhanced external counterpulsation as a novel treatment for restless legs syndrome (RLS): a preliminary test of the vascular neurologic hypothesis for RLS. Sleep Med 2005−6(2): 101−6
- Ramnarine IR, Capoccia M, Ashley Z. Counterpulsation from the skeletal muscle ventricle and the intraaortic ballon pump in the normal and failing circulations. Circulation 2006−114:1−10 -1−15
- Rauchhaus M, Kolosek V, Volk HD et al. Inflammatoty cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int J of Cardiol.2000−76 (2−3): 125−153
- Redfield MM, Rodeheffer RJ, Jacobsen SJ et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002−40(5):976−982
- Rector TS, Kubo SH, Cohn JN. Patients self-assessment of their congestive heart failure. Part 2: content, reliability and validity of a new measure, the Minnesota living with heart failure questionnaire // Heart failure. 1987−10:198−209
- Redon J, Williams B. Microalbuminuria in essential hypertension: redefining the threshold. J Hypertens 2002−20(3):353−355
- Remuzzi G, Weening JJ. Albuminuria as early test for vascular disease. Lancet. 2005−365 (9459): 556 557
- Ritz E, Fliser D, Klimm HP. Assessment of cardiovascular risk factor: The role of microalbuminuria Amsterdam 1994
- Rodeheffer RJ, Jacobsen SJ et al. The incidence and prevalence of heart failure in Rochester, Minnesota. Mayo Clin Proc. 1993- 68(12)-! 143−1150
- Rosendorff C. The renin-angiotensin system and vascular hypertrophy. J Am Coll Cardiol 1996- 28:80−812
- Rousseau M, Gurne O, van Eyll С et al. Effects of benazeprilat on left ventricular systolic and diastolic function and neurohumoral status in patients with ischemic heart disease. Circulation- 1990−81 (2 Suppl):III123−129
- Ruilope LM et al. Renal function: the Cinderella of cardiovascular risk profile. J Am Coll Cardiol, 2001- 38(7): 1782−7
- Ruilope LM, Segura J, Campo С et al. Renal participation in cardiovascular risk in essential hypertension. Expert Rev Cardiovasc Ther.2003- 1(2): 309−315
- Ruilope LM, van Veldhuisen DJ, Ritz E et al. Kidney dysfunction: a sensitive prcdictor of cardiovascular risk. Am J Hypertens 2001 -14 (6Pt2)-213S-217S
- Samak MJ, Levey AS, Schoolwerth AC et al. Kidney Disease as a risk Factor for Development of Cardiovascular Disease. Circulation 2003−108(17):2154−2169
- Schnermann J, Weihprecht H, Briggs JP. Inhibition of tubuloglomerular feedback during adenosine 1 receptor blockade. Am J Physiol. 1990−258(3Pt2):F553−561
- Schunkert H, Hense HW, Muscholl M, Luchner A, Kurzinger S, Danser AH, Riegger GA. Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass. Heart 1997- 77: 24−31.
- Schlaich MP, Schobel HP, Hilgers K, Schmieder RE. Impact of aldosterone on left ventricular structure and function in young normotensive and mildly hypertensive subjects. Am J Cardiol 2000- 85: 1199−1206.
- Sinvhall RM, Gowdal RM and Khan IA. Enhanced external counterpulsation for refractory angina pectoris. Heart 2003−89:830−833
- Solignac A, Ferguson RJ, Bourassa MG. External counterpulsation: coronary hemodynamics and use in treatment of patients with stable angina pectoris. Cathet Cardiovasc Diagn 1977,3:37−45
- Soran O, Fleishman B, Demarco T et al. Enhanced external counterpulsation in patients with heart failure: A multicenter feasibility study. Congest Heart Fail 2002−8(4):204−8,227
- Soran O, Kennard ED. Kelsey S et al. Enhanced external counterpulsation as treatment for chronic angina in patients with left ventricular disfunction: a report from the International EECP Patient Registry. Congest Heart Fail 2002,6:297−302,312
- Soroff HS, Birtwell WC, Giron F et al. Support of systemic circulation and left ventricular assist by synchronous pulsation of extramural pressure. Surg. Forum 16, 1965, 148
- Soroff HS, Birtwel WC, Levine HS et al. Effect of counterpulsation upon myocardial oxygen consumption and heart work. Surg Forum Am Coll of Surg. 1962−13:174−176
- Soufer R., Wonlgelernter D., Vita N.A. et al. Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol 1985−55:1032−36.
- Stys TP, Lawson WE, Hui JCK, et al. Effects of enhanced external counterpulsation on stress radionuclide coronary perfusion and exercise capacity in chronic stable angina pectoris. Am J Cardiol. 2002−89:822−824
- Stys T, Lawson WE, Hui JCK, Lang G, Liuzzo J, Cohn PF. Acute hemodynamic effects and angina improvement with enhanced external counterpulsation. Angiology. 2001−52:653−658
- Suresh K, Simandl S, Lawson WE, et al. Maximizing the hemodynamic benefit of enhanced external counterpulsation. Clin Cardiol. 1998−21:649−653
- Taguchi I, Ogawa К, Kanaya T et al. Effects of enhanced external counterpulsation on hemodynamics and its mechanism. Circulation 2004−68:1030−1034
- Taguchi I, Ogawa K, Olida A et al. Comparison of hemodinamic effects of enhanced external counterpulsation and intra-aortic ballon pumping in patients with acute myocardial infarction. Am J Cardiol. 2000−86(10): 1139−1141
- Takeuchi M, Nohtomi Y, Yoshitani H et al. Enhanced coronary flow velocity during intra-aortic ballon pumping assessed by transthoracic Doppler echocardiography. J Am Coll Cardiol. 2004−43(30:368−376
- Tartaglia J, Stenerson J, Charney R et al. Exercise capability and myocadial perfusion in chronic angina patients treated with enhanced external counterpulsation. Clin Cardiol 2003−26:287−290
- The SOLVD investigators. Effect of enelapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Eng J Med 1991- 325:293−302.
- The SOLVD investigators. Effect of enelapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Eng J Med 1992- 327: 685−91.
- Tian G, Cui Y. The clinical analysis of 166 cases with cerebral infarction treated by enhanced external counterpulsation. Chinese Journal of Cardiovascular Rehabilitation Medicine 1998−7(3):46−47
- Traub O, Berk ВС. Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Aterioscler Thromb Vase Biol. 1998- 18(5):677−85
- Troughton R., Frampton C., Yandle T. et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000−355:1126−1130
- Tsutamoto T, Wada A, Sakai H et al. Relationship between renal function and plasma natriuretic peptide in patients with heart failure. J Am Coll Cardiol. 2006:47(3):582−586
- Ulfendahl HR, Wolgast M. Renal circulation and lymphatics. In Seldin D.W. «The Kidney» N. Y, Raven Press, 1992, chapter 30
- Vasomedical, Inc http://www.vasomedical.com
- Voci P, Pizzuto F, Romeo F. Coronary flow: a new asset for the echo lab? Eur Heart Journal-2004−25, 1867−1879
- Wang TJ, Larson MG, Levy D. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004−12−350(7):655−663
- Weeler DC, Baigent C. Cardiovascular risk factors in chronic renal failure. Cardiovascular Disease in End-stage Renal Failure. Oxford Clinical Nephrology Series. 2000:3−29
- Werner D, Marthol H, Brown CM et al. Changes of cerebral blood flow velocities during enhanced external counterpulsation. Acta Neurol Scand 2003−107(6):405−11
- Werner D, Michelson G, Harazny J et al. Changes in ocular blood flow velocities durin external counterpulsation in healthy volunteers and patients with atherosclerosis. Graefes Arch Clin Exp Ophthalmol 2001 -239(8):599−602
- Werner D, Schneider M, Weise M, Nonnast-Daniel B, Daniel WG. Pneumatic external counterpulsation: a new noninvasive method to improve organ perfusion. Am J Cardiol 1999−84:950−2.
- Werner D, Tragner P, Wawer A et al. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis. Nephrol Dial Transplant 2005−20(5):920−6
- Wu GF, Qiang SZ, Zheng ZS et al. A neurohormonal mechanism for the effectiveness of enhanced external counterpulsation (abstract) Circulation 1999−100:1−832
- Yamamoto K., Redfield M.M., Nishimura R.A. Analysis of left ventricular diastolic function. Heart 1996−75(suppl 2):27−35.
- Yoshimura M., Mizuno Y., Nakamura M. et al. B-type natriuretic peptide as a marker of the effects of enalapril 4 in patient with heart failure. Am J Med 2002−12:9:716—720
- Yu M, Yu YL, Wang Y. The clinical application of enhanced external counterpulsation in treating oculopathy. Journal of Ophthalmology Combination of Chinese Traditional Medicine and Western Medicine 1995 -2:107
- Yuyun MF, Khaw KT, Luben R et al. A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British population- the EPIC-Norfolk study. Am J Epidemiol.2004- 159 (3): 284 293
- Zhang Y, He X, Chen X et al. Enhanced external counterpulsation inhibits intimal hyperplasia by modifying shear stress responsive gene expression in hypercholesterolemic pigs. Circulation 2007−116:526−534
- Zheng ZS, Li TM, Kambic H et al. Sequenced external counterpulsation (SECP) in China. Trans Am Soc Artif Intern Organs. 1983- 29:599−603.
- Zhuang H, Wei N, et al. The study of enhanced external counterpulsation on chronic nephritis. Central Plains Medical Journal 2000−27(3):6−7